Week In Review: CanSino Publishes Positive Data From Trial Of COVID-19 Vaccine
May 23, 2020 at 15:41 PM EDT
Tianjin CanSinoBIO published positive results from a China Phase I trial of its COVID-19 vaccine in the prestigious British journal, The Lancet. In the study, the Ad5 vectored COVID-19 vaccine was immunogenic at 28 days post-vaccination.
